HeartSciences Inc.
HSCSNASDAQHealthcare● Active
$1.84
$-0.10(-5.15%)
Market Cap$3987740
P/E Ratio—
52W High$6.47
52W Low$1.63
HeartSciences Inc. (HSCS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HSCS · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 16, 2026EPS Actual
-$0.63
Est. -$0.84 · +25.0%
Revenue
—
Est. $0.00B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 16, 2026
After Market Close
▲ Beat EPS🔥 4-Quarter EPS Beat Streak
HSCS reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.19
Rev. $0.35B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.19
Rev. Est.$0.35B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 23, 2026 | -$0.68 | — | — | — | $0.00B | — |
| ▲ Q1 FY2026 | Mar 16, 2026 | -$0.84 | -$0.63 | +25.0% | — | $0.00B | — |
| ▲ Q4 FY2025 | Dec 15, 2025 | -$0.90 | -$0.85 | +5.6% | $0.00B | — | — |
| ▲ Q3 FY2025 | Sep 11, 2025 | -$2.41 | -$1.58 | +34.4% | $0.00B | — | — |
| ▲ Q3 FY2025 | Jul 24, 2025 | -$2.51 | -$1.88 | +25.1% | $0.00B | — | — |
| ▼ Q1 FY2025 | Mar 13, 2025 | -$2.53 | -$2.57 | -1.6% | — | — | — |
| ▲ Q4 FY2024 | Dec 16, 2024 | -$2.30 | -$2.27 | +1.3% | — | — | — |
| ▼ Q3 FY2024 | Sep 12, 2024 | -$2.46 | -$2.64 | -7.3% | — | — | — |
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
-$0.68
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 16, 2026Beat
EPS Actual
-$0.63
EPS Est.
-$0.84
EPS Surpr.
+25.0%
Revenue
—
Q4 FY2025
Dec 15, 2025Beat
EPS Actual
-$0.85
EPS Est.
-$0.90
EPS Surpr.
+5.6%
Revenue
$0.00B
Q3 FY2025
Sep 11, 2025Beat
EPS Actual
-$1.58
EPS Est.
-$2.41
EPS Surpr.
+34.4%
Revenue
$0.00B
Q3 FY2025
Jul 24, 2025Beat
EPS Actual
-$1.88
EPS Est.
-$2.51
EPS Surpr.
+25.1%
Revenue
$0.00B
Q1 FY2025
Mar 13, 2025Miss
EPS Actual
-$2.57
EPS Est.
-$2.53
EPS Surpr.
-1.6%
Revenue
—
Q4 FY2024
Dec 16, 2024Beat
EPS Actual
-$2.27
EPS Est.
-$2.30
EPS Surpr.
+1.3%
Revenue
—
Q3 FY2024
Sep 12, 2024Miss
EPS Actual
-$2.64
EPS Est.
-$2.46
EPS Surpr.
-7.3%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Q1 FY2028 | $-0.51 | $-0.51 | $-0.51 | 1 |
| Q4 FY2027 | $-0.67 | $-0.67 | $-0.67 | 1 |
| Q3 FY2027 | $-0.72 | $-0.72 | $-0.72 | 1 |
| Q2 FY2027 | $-0.74 | $-0.74 | $-0.74 | 1 |
| Q1 FY2027 | $-0.77 | $-0.77 | $-0.77 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Mar 16, 2026 | +25.0% | $2.57 | $2.66 | +3.50% |
| ▲ Q4 FY2025 | Dec 15, 2025 | +5.6% | $2.55 | $2.47 | -3.14% |
| ▲ Q3 FY2025 | Sep 11, 2025 | +34.4% | $3.31 | $3.34 | +0.91% |
| ▲ Q3 FY2025 | Jul 24, 2025 | +25.1% | $3.83 | $3.93 | +2.61% |
| ▼ Q1 FY2025 | Mar 13, 2025 | -1.6% | $2.96 | $3.05 | +3.04% |
| ▲ Q4 FY2024 | Dec 16, 2024 | +1.3% | $3.77 | $3.85 | +2.12% |
| ▼ Q3 FY2024 | Sep 12, 2024 | -7.3% | $2.82 | $2.79 | -1.06% |
| ▼ Q3 FY2024 | Jul 29, 2024 | -437.4% | $4.58 | $4.11 | -10.26% |
Q1 FY2026+3.50%
Report Date
Mar 16, 2026
EPS Beat/Miss
+25.0%
Price Before
$2.57
Price After
$2.66
Q4 FY2025-3.14%
Report Date
Dec 15, 2025
EPS Beat/Miss
+5.6%
Price Before
$2.55
Price After
$2.47
Q3 FY2025+0.91%
Report Date
Sep 11, 2025
EPS Beat/Miss
+34.4%
Price Before
$3.31
Price After
$3.34
Q3 FY2025+2.61%
Report Date
Jul 24, 2025
EPS Beat/Miss
+25.1%
Price Before
$3.83
Price After
$3.93
Q1 FY2025+3.04%
Report Date
Mar 13, 2025
EPS Beat/Miss
-1.6%
Price Before
$2.96
Price After
$3.05
Q4 FY2024+2.12%
Report Date
Dec 16, 2024
EPS Beat/Miss
+1.3%
Price Before
$3.77
Price After
$3.85
Q3 FY2024-1.06%
Report Date
Sep 12, 2024
EPS Beat/Miss
-7.3%
Price Before
$2.82
Price After
$2.79
Q3 FY2024-10.26%
Report Date
Jul 29, 2024
EPS Beat/Miss
-437.4%
Price Before
$4.58
Price After
$4.11
Avg Beat Reaction+1.20%
Avg Miss Reaction-2.76%
Beat Rate5 / 8 quarters
Largest Move-10.26% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HSCS ends December
HeartSciences Inc. (HSCS) most recently reported earnings on March 16, 2026 for Q1 FY2026, posting EPS of $-0.63 — beating the analyst consensus of $-0.84 by +25.0%. HSCS has beaten EPS estimates for 4 consecutive quarters. The next HSCS earnings date is expected around September 1, 2026.
Each quarter, investors track HSCS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HSCS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HSCS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HSCS earnings · 5 questionsHeartSciences Inc.'s next earnings report is expected around September 1, 2026. HSCS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HSCS historically reports after market close (AMC).
HSCS earnings datewhen is HSCS earningsHSCS next earnings datewhen does HSCS report earningsHSCS earnings calendar
▸ Source: FMP · HeartSciences Inc. SEC filings · US GAAP · HeartSciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026